Extracellular Matrix Market to 2027 - Global Analysis and Forecasts By Application (Vascular Repair and Reconstruction, Dural Repair, Wound Healing, Cardiac Repair, Pericardial Repair, Soft Tissue Repair); Raw Material (Bovine, Porcine, Other Raw Material)and Geography

Publication Month: Jun 2019 | Report Code: TIPRE00004925 | No. of Pages: 146 | Category: Medical Device | Status: Published

UPDATE AVAILABLE ON-DEMAND
Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

The Extracellular Matrix in healthcare market was valued at US$ 24.30 million in 2018 and it is projected to reach US$ 47.46 million by 2027; it is expected to grow at a CAGR of 7.8% from 2019 to 2027.

 

Extracellular matrix is present in outer side of the tissues and it helps tissues to bind the cells with collagen. It consists of structural proteins, glycoproteins, glycosaminoglycan and proteoglycans. Extracellular matrix enables recipient cells to regrow and thus it is used in various applications which include cardiac and vascular repair procedure. The growth of the Extracellular Matrix in healthcare market is attributed to the growth of the market are significantly increasing incidences of trauma and cardiovascular diseases, increasing vascular reconstruction procedures and increasing product launches. The market for the extracellular matrix is an emerging market which is has some challenges among which one of the challenge is using of decellularized extracellular matrix for the cardiovascular conditions.

 

The Extracellular Matrix in healthcare market is expected to witness substantial growth post-pandemic. The COVID-19 has affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the COVID-19 pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increased demand for invitro diagnostic products and rising research and development activities worldwide. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out and delayed or prolonged equipment procurement. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches is also expected to pave the way for entirely virtual trials in the future. New technologies such as mRNA is expected to emerge and shift the pharmaceutical industry and market is also expected to witness more vertical integration and joint ventures in coming years.

 

Lucrative Regions for Extracellular Matrix in Healthcare Market

Lucrative Regions for Extracellular Matrix in Healthcare Market

Get more information on this report :


 

Market Insights

Growing Applications of Extracellular Matrix in Healthcare to Drive Extracellular Matrix in Healthcare Market Growth

The significantly rising incidences of the orthopedic trauma conditions and cardiovascular diseases among others are the leading factors for the market growth. As a part of the treatment extracellular matrix serve several advantages for treating different chronic injuries caused due to surgery, accidents, chronic diseases and others.

Chronic diseases such as cancer, heart diseases, musculoskeletal diseases, and others are the leading causes of death and disability. The awareness about the technologically advanced treatment and minimally invasive procedures demands treatments that are effective in less time. Thus, one of the advantage of the extracellular matrix serve the demand of the patients. However, technically advanced procedures requires higher care cost, for instance, according to the National Center for Chronic Disease Prevention and Health Promotion, chronic diseases takes up US$3.3 trillion in annual health care costs. Therefore, the higher expenditures are also expected to drive the growth of market and provide better services.

In addition, the surgical orthopedic treatment including joint arthroscopy, fracture repair, general repair procedures on damaged muscle or tendon and corrective surgery requires extracellular matrix. These conditions are generally caused due to the sports and road accidents. For instance, according to the National Safety Council, in 2015, in the US, population in the age group from 5 to 14 accounted to 51% of total football injuries treated in emergency rooms. Also, as per the Fédération Internationale de Football Association (FIFA) stated that the knee, ankle, and hamstring incur the most orthopedic injuries. The total of football injuries treated at the U.S. hospital emergency rooms were approximately 239,943. Out of these injuries nearly 79,384 were strains and sprains, around 48,806 were fractures, and nearly 5,401 were dislocations.

Moreover, the incidences of the heart failure and myocardial infraction are increasing among the ageing population. The minimally invasive treatment for these cardiovascular treatments procedures requires extracellular matrix. During the heart disease a patient fails to restore the functional properties of cardiac tissue. Therefore, the ability of the extracellular matrix to regrow and to promote adaptive repair and regeneration enables patients to recover its normal functions. Also it has shown promising clinical outcomes for tissue engineering in the treatment of cardiovascular diseases and other health conditions. 

Furthermore the rising incidences of cardiovascular diseases are expected to drive the growth for the extracellular matrix. For instance according to WHO data published in 2017, states that, in 2016, approximately 17.9 million people died from

CVDs, which was 31.0% of all the global deaths. Among these approximately 85% were due to heart attack and stroke. According to the European Cardiovascular Disease Statistics 2017, in Europe, every year cardiovascular disease (CVD) causes 3.9 million deaths and more than 1.8 million deaths in the European Union (EU). 

The CVD accounts for 45.0% of all deaths in Europe and 37.0% of all deaths in the EU. CVD is the major reason of the death in men and women in all countries. Furthermore, as per the American Heart Association (AHA) 2019 statistics, 121.5 million adults in the U.S. which is around half of the US adult population, suffers from cardiovascular disease.

The potential of regenerative medicine that facilitates tissue regeneration in the affected area reduced the requirement of tissue transplant. The extracellular matrix is derived from a readily available tissue source, it can stimulate the growth of tissue in vivo with minimal inflammation, and it is available off the shelf. These advantages of the extracellular matrix enables in the ideal soft tissue replacement treatment procedures to repair contour defects. 

The increasing vascular reconstruction or the plastic surgeries are anticipated to grow the extracellular matrix during the forecast period. According to the American Society of Plastic Surgeons (ASPS) states that in 2018, across US approximately 17.7 million surgical and minimally invasive aesthetic procedures were performed. This accounts nearly 277,000 more cosmetic procedures performed in 2017. In addition, nearly 2.68 million procedures were performed for soft tissue repair fillers and this surgery has grown by 2% from 2017.

Moreover, the rise in the treatment for the musculoskeletal diseases are also expected to drive the market growth. For instance, according to WHO it is reported that between 20%–33% of people across the globe live with a painful musculoskeletal condition. Musculoskeletal diseases are one of the most common causes of severe and long-term pain as well as physical disability in the US. According to the American Society of Orthopedic Surgeons (ASOS), an estimated 126.6 million Americans in 2016 were affected by a musculoskeletal condition. 

Moreover, the studies have shown positive results of extracellular matrix to treat various cancers as it plays important role for restraining the growth of the cancer cells. Most of major cell behavior and developmental processes are targeted for the deregulation of the cancer cells. Thus, benefits of the extracellular matrix are enabling to treat cancer effectively, and the rising number of cases cancer cases are likely to demand extracellular matrix. Thus, owing to the above mentioned factors the market is likely to grow significantly during the forecast period.

The market for the extracellular matrix is majorly driven by the increasing product launches in market. The market is experiencing increase in the number of the market players. The market players are involved in various developmental activities that has resulted into product launches. The below table enlists the recent product launches in the extracellular matrix market. The below enlisted products has enabled market players to mark a good position in the global extracellular matrix market. The products have met the requirement and demand of the healthcare professionals to treat patients.

Also it is expected that such more product launches are likely to drive the growth of the market during the forecast period.

 

Application -Based Insights

In terms of application, the Extracellular Matrix in healthcare market is segmented into vascular repair and reconstruction, dural repair, wound healing, cardiac repair, pericardial repair, soft tissue repair. In 2018, the soft tissue repair segment held a largest market share of 26.46% of the extracellular matrix market, by application.

 

Extracellular Matrix in Healthcare Market, by Application – 2018 and 2027

Extracellular Matrix in Healthcare Market, by Application – 2018 and 2027

Get more information on this report :


 

Raw Materials-Based Insights

In terms of raw materials, the Extracellular Matrix in healthcare market is segmented into bovine, porcine, other raw material. In 2018, the porcine held a largest market share of 41.09% of the extracellular matrix market, by raw material.


Strategic Insights

The Extracellular Matrix in healthcare market players are adopting the product launch and expansion strategies to cater to changing customer demands worldwide, which also allows them to maintain their brand name globally.

 

Extracellular Matrix in Healthcare Market – by Application

  • Robot Assisted Surgery
  • Virtual Assistants
  • Administrative Workflow Assistants
  • Connected Machines
  • Diagnosis

Extracellular Matrix in Healthcare Market – by Raw Materials

  • Hospitals & Healthcare Providers
  • Patients
  • Pharma & Biotech Companies
  • Healthcare Payers
  • Others

Extracellular Matrix in Healthcare Market – by Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South America and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM

 

Company Profiles

  • Admedus
  • Coloplast Group
  • Merck KGaA
  • Smith & Nephew
  • MTF Biologics
  • Lattice Biologics Ltd.
  • COOK BIOTECH, INC.
  • Medtronic
  • Aziyo Biologics, Inc.
  • DSM Biomedical

 

1.             INTRODUCTION

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       market segmentation

1.3.1        Global Extracellular Matrix Market – By Application

1.3.2        Global Extracellular Matrix Market – By Raw Material

1.3.3        Global Extracellular Matrix Market – By Geography

2.             Global Extracellular Matrix market – Key takeaways

3.             research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Extracellular Matrix– market landscape

4.1       overview

4.2       pest analysis

4.2.1        North America – PEST Analysis

4.2.2        Europe – PEST Analysis

4.2.3        Asia Pacific– PEST Analysis

4.2.4        Middle East And Africa– PEST Analysis

4.2.5        South & Central America – PEST Analysis

5.             Global extracellular matrix market –  Key Industry Dynamics

5.1       Key Market Drivers

5.1.1        Significantly Increasing Incidences Of Trauma And Cardiovascular Diseases

5.1.2        Increasing Vascular Reconstruction Procedures

5.1.3        Increasing Product Launches

5.2       Key Market Challenge

5.2.1        Challenges During The Usage Of Decellularized Extracellular Matrix

5.3       Key Market Opportunities

5.3.1        Opportunities To Treat Cancer

5.3.2        Growth Opportunities in The Developing Nations

5.4       Impact Analysis of Drivers and Challenges

6.             extracellular matrix market – Global Analysis

6.1       global extracellular matrix market Revenue Forecasts and Analysis

6.2       global extracellular matrix market, By Geography - Forecasts and Analysis

6.3       PERFORMANCE/ Positioning OF KEY PLAYERS

6.3.1        Smith & Nephew

6.3.2        DSM Biomedical

7.             Extracellular Matrix Market Analysis and forecasts to 2027 – Application

7.1       Overview

7.2       global extracellular matrix market share by application 2018 & 2027 (%)

7.3       Vascular Repair and reconstruction Market

7.3.1        Overview

7.3.2        Vascular Repair and Reconstruction Market Revenue and Forecast to 2027 (US$ Mn)

7.4       Dural repair Market

7.4.1        Overview

7.4.2        Dural Repair Market Revenue and Forecast to 2027 (US$ Mn)

7.5       Wound HEaling Market

7.5.1        Overview

7.5.2        Wound Healing Market Revenue and Forecast to 2027 (US$ Mn)

7.6       Cardiac repair Market

7.6.1        Overview

7.6.2        Cardiac Repair Market Revenue and Forecast to 2027 (US$ Mn)

7.7       periCardial repair Market

7.7.1        Overview

7.7.2        Pericardial Repair Market Revenue and Forecast to 2027 (US$ Mn)

7.8       Soft Tissue repair Market

7.8.1        Overview

7.8.2        Soft Tissue Repair Market Revenue and Forecast to 2027 (US$ Mn)

8.             extracellular matrix MARKET ANALYSIS AND FORECASTS TO 2027 – Raw material

8.1       overview

8.2       global extracellulr matrix market share by raw material 2018 & 2027 (%)

8.3       bovine market

8.3.1        Overview

8.3.2        Bovine Market Revenue and Forecast to 2027 (US$ Mn)

8.4       Porcine market

8.4.1        Overview

8.4.2        Porcine Market Revenue and Forecast to 2027 (US$ Mn)

8.5       Others market

8.5.1        Overview

8.5.2        Others Market Revenue and Forecast to 2027 (US$ Mn)

9.             extracellular matrix MARKET REVENUE AND FORECASTS TO 2027 – GeographicAL ANALYSIS

9.1       North America extracellular matrix market

9.1.1        Overview

9.1.2        North America Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.1.3        North America Extracellular Matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

9.1.4        North America Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material  (US$ Thousand)

9.1.5        North America Extracellular Matrix Market Revenue and Forecasts to 2027, By Country (%)

9.1.6        US Extracellular Matrix Market

9.1.6.1      US Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.1.6.2      US Extracellular Matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

9.1.6.3      US Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material (US$ Thousand)

9.1.7        Canada Extracellular Matrix Market

9.1.7.1      Canada Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.1.7.2      Canada Extracellular Matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

9.1.7.3      Canada Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material (US$ Thousand)

9.1.8        Mexico Extracellular Matrix Market

9.1.8.1      Mexico Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.1.8.2      Mexico Extracellular Matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

9.1.8.3      Mexico Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material (US$ Thousand)

9.2       Europe Extracellular matrix Market

9.2.1        Overview

9.2.2        Europe Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.2.3        Europe Extracellular Matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

9.2.4        Europe Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material (US$ Thousand)

9.2.5        Europe Extracellular Matrix Market Revenue and Forecasts to 2027, By Country (%)

9.2.6        Germany Extracellular Matrix Market

9.2.6.1      Germany Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.2.6.2      Germany Extracellular Matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

9.2.6.3      Germany Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material (US$ Thousand)

9.2.7        UK Extracellular Matrix Market

9.2.7.1      UK Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.2.7.2      UK Extracellular Matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

9.2.7.3      UK Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material (US$ Thousand)

9.2.8        France Extracellular Matrix Market

9.2.8.1      France Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.2.8.2      France Extracellular Matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

9.2.8.3      France Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material (US$ Thousand)

9.2.9        Spain Extracellular Matrix Market

9.2.9.1      Spain Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.2.9.2      Spain Extracellular Matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

9.2.9.3      Spain Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material (US$ Thousand)

9.2.10     Italy Extracellular Matrix Market

9.2.10.1    Italy Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.2.10.2    Italy Extracellular Matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

9.2.10.3    Italy Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material (US$ Thousand)

9.3       Asia Pacific Extracellular matrix market

9.3.1        Overview

9.3.2        Asia Pacific Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.3.3        Asia Pacific Extracellular Matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

9.3.4        Asia Pacific Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material  (US$ Thousand)

9.3.5        Asia Pacific Extracellular Matrix Market Revenue and Forecasts to 2027, By Country (%)

9.3.6        China Extracellular Matrix Market

9.3.6.1      China Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.3.6.2      China Extracellular Matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

9.3.6.3      China Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material (US$ Thousand)

9.3.7        Japan Extracellular Matrix Market

9.3.7.1      Japan Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.3.7.2      Japan Extracellular Matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

9.3.7.3      Japan Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material (US$ Thousand)

9.3.8        India Extracellular Matrix Market

9.3.8.1      India Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.3.8.2      India Extracellular Matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

9.3.8.3      India Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material (US$ Thousand)

9.3.9        Australia Extracellular Matrix Market

9.3.9.1      Australia Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.3.9.2      Australia Extracellular Matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

9.3.9.3      Australia Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material (US$ Thousand)

9.3.10     South Korea Extracellular Matrix Market

9.3.10.1    South Korea Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.3.10.2    South Korea Extracellular Matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

9.3.10.3    South Korea Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material (US$ Thousand)

9.4       Middle East and AFrica Extracellular matrix market

9.4.1        Overview

9.4.2        Middle East and Africa Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.4.3        Middle East and Africa Extracellular Matrix Market Revenue And Forecasts to 2027, By Application  (US$ Thousand)

9.4.4        Middle East and Africa Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material (US$ Thousand)

9.4.5        Middle East and Africa Extracellular Matrix Market Revenue and Forecasts to 2027, By Country (%)

9.4.6        UAE Extracellular Matrix Market

9.4.6.1      UAE Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.4.6.2      UAE Extracellular Matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

9.4.6.3      UAE Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material (US$ Thousand)

9.4.7        Saudi Arabia Extracellular Matrix Market

9.4.7.1      Saudi Arabia Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.4.7.2      Saudi Arabia Extracellular Matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

9.4.7.3      Saudi Arabia Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material (US$ Thousand)

9.4.8        South Africa Extracellular Matrix Market

9.4.8.1      South Africa Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.4.8.2      South Africa Extracellular Matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

9.4.8.3      South Africa Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material (US$ Thousand)

9.5       South and Central America Extracellular matrix market

9.5.1        Overview

9.5.2        South and Central America Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.5.3        South and Central America Extracellular Matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

9.5.4        South and Central America Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material (US$ Thousand)

9.5.5        South and Central America Extracellular Matrix Market Revenue and Forecasts to 2027, By Country (%)

9.5.6        Brazil Extracellular Matrix Market

9.5.6.1      Brazil Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.5.6.2      Brazil Extracellular Matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

9.5.6.3      Brazil Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material (US$ Thousand)

9.5.7        Argentina Extracellular Matrix Market

9.5.7.1      Argentina Extracellular Matrix Market Revenue And Forecasts to 2027 (US$ Thousand)

9.5.7.2      Argentina Extracellular Matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

9.5.7.3      Argentina Extracellular Matrix Market Revenue And Forecasts to 2027, By Raw Material (US$ Thousand)

10.          Extracellular matrix market – Industry Landscape

10.1    Overview

10.2    Growth Strategies in the Extracellular matrix market, 2015-2019

10.3    Organic Growth Strategies

10.3.1     Overview

10.3.2     Product Launch

10.3.3     Expansion

10.3.4     Product Approval

10.4    Inorganic Growth Strategies

10.4.1     Overview

10.4.2     Agreement

10.4.3     Acquisition

10.4.4     Partnership

11.          extracellular matrix Market–Key company profiles

11.1    Admedus

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Financial Overview

11.1.4     Product Portfolio

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2    coloplast group

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Financial Overview

11.2.4     Product Portfolio

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3    Merck KGaA

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Financial Overview

11.3.4     Product Portfolio

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4    Smith & Nephew

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Financial Overview

11.4.4     Product Portfolio

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5    MTF Biologics

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Financial Overview

11.5.4     Product Portfolio

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6    Lattice Biologics Ltd.

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Financial Information

11.6.4     Product Portfolio

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7    COOK BIOTECH, INC.

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Financial Overview

11.7.4     Product Portfolio

11.7.5     SWOT Analysis

11.7.1     Key Developments

11.8    Medtronic

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Financial Information

11.8.4     Product Portfolio

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9    AZIYO BIOLOGICS, INC.

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Financial Information

11.9.4     Product Portfolio

11.9.5     SWOT Analysis

11.9.6     Key Developments

11.10 DSM Biomedical

11.10.1   Key Facts

11.10.2   Business Description

11.10.3   Financial Overview

11.10.4   Product Portfolio

11.10.5   SWOT Analysis

11.10.6   Key Developments

12.          Appendix

12.1    About The Insight Partners

12.2    Glossary of Terms


list of tables

TABLE 1.           Recent Product Launch in extracellular matrix market

TABLE 2.           North America Extracellular matrix Market Revenue And Forecasts to 2027, By Application (US$ Thousand)

TABLE 3.           North America Extracellular matrix Market Revenue And Forecasts to 2027, By raw material (US$ Thousand)

TABLE 4.           US Extracellular matrix Market Revenue And Forecasts to 2027, By application (US$ Thousand)

TABLE 5.           US Extracellular matrix Market Revenue And Forecasts to 2027, By raw material  (US$ Thousand)

TABLE 6.           Canada Extracellular matrix Market Revenue And Forecasts to 2027, By application  (US$ Thousand)

TABLE 7.           Canada Extracellular matrix Market Revenue And Forecasts to 2027, By raw material  (US$ Thousand)

TABLE 8.           Mexico Extracellular matrix Market Revenue And Forecasts to 2027, By application  (US$ Thousand)

TABLE 9.           Mexico Extracellular matrix Market Revenue And Forecasts to 2027, By raw material  (US$ Thousand)

TABLE 10.        Europe Extracellular matrix Market Revenue And Forecasts to 2027, By Application  (US$ Thousand)

TABLE 11.        Europe Extracellular matrix Market Revenue And Forecasts to 2027, By raw material  (US$ Thousand)

TABLE 12.        Germany Extracellular matrix Market Revenue And Forecasts to 2027, By application  (US$ Thousand)

TABLE 13.        Germany Extracellular matrix Market Revenue And Forecasts to 2027, By raw material (US$ Thousand)

TABLE 14.        UK Extracellular matrix Market Revenue And Forecasts to 2027, By application (US$ Thousand)

TABLE 15.        UK Extracellular matrix Market Revenue And Forecasts to 2027, By raw material  (US$ Thousand)

TABLE 16.        France Extracellular matrix Market Revenue And Forecasts to 2027, By application  (US$ Thousand)

TABLE 17.        France Extracellular matrix Market Revenue And Forecasts to 2027, By raw material  (US$ Thousand)

TABLE 18.        Spain Extracellular matrix Market Revenue And Forecasts to 2027, By application  (US$ Thousand)

TABLE 19.        Spain Extracellular matrix Market Revenue And Forecasts to 2027, By raw material  (US$ Thousand)

TABLE 20.        Italy Extracellular matrix Market Revenue And Forecasts to 2027, By application  (US$ Thousand)

TABLE 21.        Italy Extracellular matrix Market Revenue And Forecasts to 2027, By raw material  (US$ Thousand)

TABLE 22.        Asia Pacific Extracellular matrix Market Revenue And Forecasts to 2027, By Application  (US$ Thousand)

TABLE 23.        Asia Pacific Extracellular matrix Market Revenue And Forecasts to 2027, By raw material (US$ Thousand)

TABLE 24.        China Extracellular matrix Market Revenue And Forecasts to 2027, By application  (US$ Thousand)

TABLE 25.        China Extracellular matrix Market Revenue And Forecasts to 2027, By raw material  (US$ Thousand)

TABLE 26.        Japan Extracellular matrix Market Revenue And Forecasts to 2027, By application  (US$ Thousand)

TABLE 27.        Japan Extracellular matrix Market Revenue And Forecasts to 2027, By raw material  (US$ Thousand)

TABLE 28.        India Extracellular matrix Market Revenue And Forecasts to 2027, By application  (US$ Thousand)

TABLE 29.        India Extracellular matrix Market Revenue And Forecasts to 2027, By raw material  (US$ Thousand)

TABLE 30.        Australia Extracellular matrix Market Revenue And Forecasts to 2027, By application  (US$ Thousand)

TABLE 31.        Australia Extracellular matrix Market Revenue And Forecasts to 2027, By raw material  (US$ Thousand)

TABLE 32.        South Korea Extracellular matrix Market Revenue And Forecasts to 2027, By application  (US$ Thousand)

TABLE 33.        South Korea Extracellular matrix Market Revenue And Forecasts to 2027, By raw material  (US$ Thousand)

TABLE 34.        Middle East and Africa Extracellular matrix Market Revenue And Forecasts to 2027,  By Application (US$ Thousand)

TABLE 35.        Middle East and Africa Extracellular matrix Market Revenue And Forecasts to 2027,  By raw material (US$ Thousand)

TABLE 36.        UAE Extracellular matrix Market Revenue And Forecasts to 2027, By application (US$ Thousand)

TABLE 37.        UAE Extracellular matrix Market Revenue And Forecasts to 2027, By raw material (US$ Thousand)

TABLE 38.        Saudi Arabia Extracellular matrix Market Revenue And Forecasts to 2027, By application  (US$ Thousand)

TABLE 39.        Saudi Arabia Extracellular matrix Market Revenue And Forecasts to 2027, By raw material  (US$ Thousand)

TABLE 40.        South Africa Extracellular matrix Market Revenue And Forecasts to 2027, By application  (US$ Thousand)

TABLE 41.        South Africa Extracellular matrix Market Revenue And Forecasts to 2027, By raw material (US$ Thousand)

TABLE 42.        South and Central America Extracellular matrix Market Revenue And Forecasts to 2027,  By Application (US$ Thousand)

TABLE 43.        South and Central America Extracellular matrix Market Revenue And Forecasts to 2027,  By raw material (US$ Thousand)

TABLE 44.        Brazil Extracellular matrix Market Revenue And Forecasts to 2027, By application  (US$ Thousand)

TABLE 45.        Brazil Extracellular matrix Market Revenue And Forecasts to 2027, By raw material (US$ Thousand)

TABLE 46.        Argentina Extracellular matrix Market Revenue And Forecasts to 2027, By application  (US$ Thousand)

TABLE 47.        Argentina Extracellular matrix Market Revenue And Forecasts to 2027, By raw material  (US$ Thousand)

TABLE 48.        Recent Product launch in the Extracellular matrix market

TABLE 49.        Recent Expansion in the Extracellular matrix market

TABLE 50.        Recent Product approval in the Extracellular matrix market

TABLE 51.        Agreement in the Extracellular matrix market

TABLE 52.        Acquisitions in the Extracellular matrix market

TABLE 53.        partnership in the Extracellular matrix market

TABLE 54.        Glossary of Terms, Extracellular matrix market

 

list of figures

FIGURE 1.        Extracellular Matrix market Segmentation

FIGURE 2.        Extracellular matrix Segmentation, by region

FIGURE 3.        Asia Pacific contrast media agents market, Revenue (US$ Mn), 2018 & 2027

FIGURE 4.        Global extracellular matrix market By Application, Market Share (%), 2018

FIGURE 5.        Global extracellular matrix market By Raw Material, Market Share (%), 2018

FIGURE 6.        North America PEST Analysis

FIGURE 7.        Europe PEST Analysis

FIGURE 8.        asia pacific PEST Analysis

FIGURE 9.        Middle east and africa PEST Analysis

FIGURE 10.     South & Central America PEST Analysis

FIGURE 11.     extracellular matrix market Impact Analysis of Driver and challenge

FIGURE 12.     global extracellular matrix market – Revenue Forecasts and Analysis – 2018- 2027

FIGURE 13.     global extracellular matrix market – by geography Forecasts and Analysis – 2018- 2027

FIGURE 14.     MArket positioning of key player in global extracellular matrix market

FIGURE 15.     global extracellular matrix market share by Application 2018 & 2027 (%)

FIGURE 16.     vascular repair and reconstruction Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 17.     dural repair Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 18.     wound healing Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 19.     cardiac repair Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 20.     pericardial repair Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 21.     soft tissue repair Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 22.     global extracellular matrix market share by raw material 2018 & 2027 (%)

FIGURE 23.     bovine Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 24.     porcine Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 25.     others Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 26.     North America Extracellular matrix Market revenue Overview, by Country (2018)  (US$ Thousand)

FIGURE 27.     North America Extracellular matrix Market Revenue and Forecasts to 2027 (US$ Thousand)

FIGURE 28.     North America Extracellular matrix Market Revenue And Forecasts to 2027, By Country (%)

FIGURE 29.     US Extracellular matrix Market Revenue and Forecasts to 2027 (US$ Thousand)

FIGURE 30.     Canada Extracellular matrix Market Revenue and Forecasts to 2027 (US$ Thousand)

FIGURE 31.     Mexico Extracellular matrix Market Revenue and Forecasts to 2027 (US$ Thousand)

FIGURE 32.     Europe Extracellular matrix Market revenue Overview, by Country (2018) (US$ Thousand)

FIGURE 33.     Europe Extracellular matrix Market Revenue and Forecasts to 2027 (US$ Thousand)

FIGURE 34.     Europe Extracellular matrix Market Revenue And Forecasts to 2027, By Country (%)

FIGURE 35.     Germany Extracellular matrix Market Revenue and Forecasts to 2027 (US$ Thousand)

FIGURE 36.     UK Extracellular matrix Market Revenue and Forecasts to 2027 (US$ Thousand)

FIGURE 37.     France Extracellular matrix Market Revenue and Forecasts to 2027 (US$ Thousand)

FIGURE 38.     Spain Extracellular matrix Market Revenue and Forecasts to 2027 (US$ Thousand)

FIGURE 39.     Italy Extracellular matrix Market Revenue and Forecasts to 2027 (US$ Thousand)

FIGURE 40.     Asia Pacific Extracellular matrix Market revenue Overview, by Country (2018) (US$ Thousand)

FIGURE 41.     Asia Pacific Extracellular matrix Market Revenue and Forecasts to 2027 (US$ Thousand)

FIGURE 42.     Asia Pacific Extracellular matrix Market Revenue And Forecasts to 2027, By Country (%)

FIGURE 43.     China Extracellular matrix Market Revenue and Forecasts to 2027 (US$ Thousand)

FIGURE 44.     Japan Extracellular matrix Market Revenue and Forecasts to 2027 (US$ Thousand)

FIGURE 45.     India Extracellular matrix Market Revenue and Forecasts to 2027 (US$ Thousand)

FIGURE 46.     Australia Extracellular matrix Market Revenue and Forecasts to 2027 (US$ Thousand)

FIGURE 47.     South Korea Extracellular matrix Market Revenue and Forecasts to 2027 (US$ Thousand)

FIGURE 48.     Middle East and Africa Extracellular matrix Market revenue Overview, by Country (2018)  (US$ Thousand)

FIGURE 49.     Middle East and Africa Extracellular matrix Market Revenue and Forecasts to 2027  (US$ Thousand)

FIGURE 50.     Middle East and Africa Extracellular matrix Market Revenue And Forecasts to 2027,  By Country (%)

FIGURE 51.     UAE Extracellular matrix Market Revenue and Forecasts to 2027 (US$ Thousand)

FIGURE 52.     Saudi Arabia Extracellular matrix Market Revenue and Forecasts to 2027 (US$ Thousand)

FIGURE 53.     South Africa Extracellular matrix Market Revenue and Forecasts to 2027 (US$ Thousand)

FIGURE 54.     South and Central America Extracellular matrix Market revenue Overview, by Country (2018) (US$ Thousand)

FIGURE 55.     South and Central America Extracellular matrix Market Revenue and Forecasts to 2027  (US$ Thousand)

FIGURE 56.     South and Central America Extracellular matrix Market Revenue And Forecasts to 2027,  By Country (%)

FIGURE 57.     Brazil Extracellular matrix Market Revenue and Forecasts to 2027 (US$ Thousand)

FIGURE 58.     Argentina Extracellular matrix Market Revenue and Forecasts to 2027 (US$ Thousand)

FIGURE 59.     Growth Strategies in the Extracellular matrix market, 2015-2019

FIGURE 60.     Organic Growth Strategies in the Extracellular matrix market, 2015-2019

FIGURE 61.     inOrganic Growth Strategies in the Extracellular matrix market, 2015-2019

 

 

The List of Companies

  1. Admedus
  2. Coloplast Group
  3. Merck KGaA
  4. Smith & Nephew
  5. MTF Biologics
  6. Lattice Biologics Ltd.
  7. COOK BIOTECH, INC.
  8. Medtronic
  9. Aziyo Biologics, Inc.
  10. DSM Biomedical
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the extracellular matrix market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global extracellular matrix market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

TIPRE00004925
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing